greeksoup/ stock research

Chemed (CHE) Q4 FY2025 earnings: revenue $639 million, down 0.1% on the year

Chemed Corp. (CHE) reported revenue of $639 million for Q4 FY2025, the quarter ended 31 December 2025, down 0.1% on the same quarter a year earlier. Net income was $77 million, down 15.0% on the year, and diluted earnings per share $5.48. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2026.

Revenue$639 milliondown 0.1%
Net income$77 milliondown 15.0%
Diluted EPS$5.48
QuarterQ4 FY2025ended 31 December 2025

The quarter, against the one before and a year earlier

LineQ4 FY2025Q3 FY2025Q4 FY2024Change on the year
Revenue639625640-0.1%
Cost of revenue414428406+2.0%
Gross profit225197234-3.8%
Gross margin35.2%31.5%36.6%
Selling, general and administrative106106104+1.2%
Operating income10174.8114-11.6%
Operating margin15.7%12.0%17.8%
Interest expense0.50.50.5+4.4%
Pre-tax income10583.5120-12.2%
Income tax28.719.329.8-3.7%
Effective tax rate27.2%23.1%24.8%
Net income76.864.290.3-15.0%
Net margin12.0%10.3%14.1%
Diluted EPS$5.48$4.46$6.02-9.0%
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ4 FY2025Q3 FY2025Q4 FY2024Change on the year
Operating cash flow13483.4165-19.0%
Capital expenditure16.317.512.8+28.1%
Free cash flow11765.9152-23.0%
Free cash flow margin18.3%10.5%23.8%
Cash from investing-16.0-14.2-12.5n/a
Cash from financing-173-189-212n/a
Depreciation and amortisation16.316.215.8+3.2%
Buybacks175181209-16.6%
Dividends paid8.58.77.5+13.4%
Dividend per sharen/a$0.60n/an/a
Diluted shares, weighted14m14m15m-4.8%
Shares outstanding at period end14m14m15m-6.0%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ4 FY2025Q3 FY2025Q4 FY2024Change on the year
Shareholders' equity9791,0771,119-12.5%
Debt0.00.00.0n/a
Operating lease liabilities10399.598.5+4.4%
Other liabilities456447451+1.1%
Total liabilities and equity1,5381,6241,669-7.8%
Fixed assets206204201+2.4%
Goodwill667667667+0.0%
Intangible assets82.884.992.2-10.2%
Cash and equivalents74.5130178-58.2%
Receivables183216171+6.7%
Inventory7.58.28.2-7.9%
Other assets318314351-9.4%
Total assets1,5381,6241,669-7.8%

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue565586589596606640647619625639658673
Cost of revenue362358385390396406431434428414442452
Gross profit202228204206210234216185197225216221
Gross margin36%39%35%35%35%37%33%30%32%35%33%33%
SG&A99.6100116102102104106100106106114115
Operating income86.811172.388.192.211494.868.174.810184.689.2
Operating margin15%19%12%15%15%18%15%11%12%16%13%13%
Interest expense0.40.30.40.40.40.50.30.40.50.50.51.8
Pre-tax income93.311684.593.810112095.771.183.510588.891.3
Tax rate20%22%23%24%25%25%25%26%23%27%25%26%
Net income75.090.165.070.975.890.371.852.564.276.866.367.7
Net margin13%15%11%12%13%14%11%8%10%12%10%10%
Diluted EPS$4.93$5.90$4.24$4.65$5.00$6.02$4.86$3.57$4.46$5.48$4.84$5.13
Operating cash flow28.910984.577.590.516532.713983.413488.284.8
Capital expenditure11.711.812.296.418.612.813.315.817.516.317.115.5
Free cash flow17.396.872.4-18.971.915219.512365.911771.169.3
Buybacks14.3n/a38.555.857.820933.242.918117519097.5
Dividends paid6.06.16.06.17.57.57.37.28.78.58.27.9
Shares outstanding15m15m15m15m15m15m15m15m14m14m13m13m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-K for the period ended 31 December 2025, filed 27 February 2026, accession 0001562762-26-000020: the filing on EDGAR. All of Chemed Corp.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install